Clinical Trial Update: Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating endobronchial transplantation of autologous mesenchymal stem cells in patients with emphysema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emphysema

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Arda Kiani | Conditions: Emphysema | Phase 1 | Status: UNKNOWN